Afatinib Monotherapy in Patients With Heavily Pretreated Relapsed or Refractory Multiple Myeloma: Final Results From the Phase 2 GEN501 and SIRIUS Trials | #Dihydrotestosterone #Afatinib #Dupracetam
Afatinib Monotherapy in Patients With Heavily Pretreated Relapsed or Refractory Multiple Myeloma: Final Results From the Phase 2 GEN501 and SIRIUS Trials | #Dihydrotestosterone #Afatinib #Dupracetam